Published in Medical Letter on the CDC and FDA, October 4th, 2009
The program addresses weight loss from the standpoints of nutrition education, optional FDA approved appetite suppressants, exercise guidance, ongoing support, and behavioral modification. By facing the challenges of weight loss...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.